Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on May 29, 2025
Microchip Technology Raises Financial Guidance for Sales and EPS for First Quarter of Fiscal Year 2026
GlobeNewswire
·
May 29, 2025
CHANDLER, Ariz., May 29, 2025 (GLOBE NEWSWIRE) -- Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today updated the range of its prior guidance for net Sales and GAAP and non-GAAP earnings …
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Kevin Rubin Joins Zscaler as Chief Financial Officer to Drive Continued Growth
GlobeNewswire
·
May 29, 2025
SAN JOSE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced the appointment of Kevin Rubin as Chief Financial Officer. In his role, Rubin will oversee Zscaler’s global finance organization …
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today …
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
GlobeNewswire
·
May 29, 2025
LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation Poster to be presented June 2, 2025, …
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that members …
AGM Group Holdings Inc. Announces Effective Date of 50 for 1 Share Consolidation
GlobeNewswire
·
May 29, 2025
Beijing, May 29, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today …
The Lovesac Company Announces First Quarter Conference Call Date
GlobeNewswire
·
May 29, 2025
STAMFORD, Conn., May 29, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its first quarter financial results will be released before market open …
Amneal to Participate at Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company presentation at 9:20 AM ET, and …
Ambarella, Inc. Announces First Quarter Fiscal Year 2026 Financial Results
GlobeNewswire
·
May 29, 2025
SANTA CLARA, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced first quarter fiscal 2026 financial results for the period ended April 30, 2025. Revenue for the first quarter of fiscal …
Latham Group, Inc. to Participate at Upcoming Conferences in June 2025
GlobeNewswire
·
May 29, 2025
LATHAM, N.Y., May 29, 2025 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will …
Zeo Energy Corp. Receives Nasdaq Notice on Late Filing of its Form 10-Q
GlobeNewswire
·
May 29, 2025
NEW PORT RICHEY, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) “Zeo Energy” or the “Company”), announced today that, as expected, it received a notice (the “Notice”) from Nasdaq on May 22, 2025, notifying the Company that it is not …
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Zscaler Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
May 29, 2025
Third Quarter Highlights Revenue grows 23% year-over-year to $678.0 million Calculated billings grows 25% year-over-year to $784.5 million Deferred revenue grows 26% year-over-year to $1,985.0 million GAAP net loss of $4.1 million compared to GAAP net …
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
GlobeNewswire
·
May 29, 2025
FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
Mondelēz International Expands Sustainable Futures Portfolio Aiming to Accelerate Scalable Climate and Community Initiatives
GlobeNewswire
·
May 29, 2025
New investments span regenerative agriculture, inclusive financing, and circular packaging ambitions through innovative technology. Investments reflect the company’s three-pronged approach across direct investments, fund investments, and technical …
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
GlobeNewswire
·
May 29, 2025
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will …
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
GlobeNewswire
·
May 29, 2025
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – …
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global Healthcare Conference on Thursday, June 5 …
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) …